Back

The relative importance of particle count, type, and size of ApoB-containing lipoproteins in risk of myocardial infarction

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Role of lipids in clinical setting Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Jakub Morze

Chalmers University of Technology, Gothenburg (Sweden)

3 More presentations in this session

Presentation thumbnail
Lipoprotein(a) in progressive coronary artery disease: beyond classical cardiovascular risk parameters
Doctor J. Sangha (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Cumulative dyslipidaemia from mid-adolescence through young adulthood with carotid intima-media thickness progression: a 9-year longitudinal study
Doctor A. Agbaje (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Cholesterol remnants distribution in patients admitted for acute coronary syndrome
Doctor A. Cordero (Alicante, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Role of lipids in clinical setting

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) cardiovascular disease risk not captured by low density lipoprotein cholesterol and apolipoprotein B
thumbnail
Congress Presentation
Elevated remnant cholesterol confers high risk of ASCVD without prompting lipid-lowering therapy: an unmet medical need
thumbnail
Congress Presentation
The prevalence, patients characteristics and risk factors of hyper-Lp(a)-emia in the Polish population. The first results from the PMMHRI-Lp(a) Registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources